Pharmacists are in the best position to counsel and educate patients on anticoagulant agents such as NOACs. This should enable patients to play a more active role in their treatment and ultimately enhance adherence behaviour. However, educational elements should be targeted to knowledge. Thus, the investigators will develop and validate a questionnaire that can assess knowledge about NOACs
Study Type
OBSERVATIONAL
Enrollment
60
Patients will receive several questionnaires to fill in. Knowledge about NOACs will be assessed with a newly developped questionnaire and an educational program will be dispensed while analysing the answers (reactive educational program).
University of Basel, Pharmaceutical Care Research Group
Basel, Canton of Basel-City, Switzerland
Validation of the new questionnaire assessed by questionnaire
Patients will rate on a 4-point likert scale feasibility, acceptability and comprehension of the new questionnaire immediately after the questionnaire had been filled in the first time.
Time frame: measured once at visit 1 (baseline)
Sensitivity of the new questionnaire
Number of correct/incorrect answers measured at visit 2 before and after the educational program has been dispensed (7 days after visit 1)
Time frame: 7 days after visit 1, before and after the educational program
Test retest validity of the new questionnaire
Number of correct/incorrect answers measured at visit 1 and 2 (0 respectively 7 days after visit 1)
Time frame: 7 days
Patient's adherence assessed by questionnaire
change in adherence between visits 1 (baseline) and visit 3
Time frame: 14 days
Patient's satisfaction assessed by questionnaire
change in satisfaction between visits 1 (baseline) and visit 3
Time frame: 14 days
Patient's health literacy assessed by questionnaire
Time frame: assessed once at visit 1 (baseline assessment)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.